NOVA PHARMACEUTICAL CORPORATION – Trademark Portfolio

Entity Type: 11

NOVA PHARMACEUTICAL CORPORATION holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GLIADEL. The owner is based in BALTIMORE, MD.

6200 FREEPORT CENTRE

BALTIMORE, MD 212242788

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

NOVA PHARMACEUTICAL CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does NOVA PHARMACEUTICAL CORPORATION have?

NOVA PHARMACEUTICAL CORPORATION has 11 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 7 cancelled.

What trademark classes does NOVA PHARMACEUTICAL CORPORATION file in?

NOVA PHARMACEUTICAL CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are NOVA PHARMACEUTICAL CORPORATION's most well-known trademarks?

NOVA PHARMACEUTICAL CORPORATION's registered trademark portfolio includes well-known marks such as GLIADEL. These are among 1 currently registered trademark in the portfolio.

What is NOVA PHARMACEUTICAL CORPORATION's trademark registration success rate?

NOVA PHARMACEUTICAL CORPORATION has a 9% trademark registration rate, with 1 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.